Photrexa cross-linking kit 6ML
Ended Awarded
- Contract number
- SPE2DB25FQAKB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,117
Award facts
- Contract value 100% obligated
- $11,116.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,116.77 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml) on September 26, 2025, with an ultimate completion date of October 20, 2025. The contract employs firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its facility in Park Ridge. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products supporting military healthcare facilities nationwide.
Photrexa is a specialized pharmaceutical product used in corneal cross-linking procedures for ophthalmology treatments. Through its expansive IDC vehicle, DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, providing comprehensive pharmaceutical distribution services including branded and generic prescription drugs, biologics, medical consumables, and specialty medications to Department of Defense healthcare facilities. The company's consistent award history with the Defense Logistics Agency demonstrates its capability to reliably supply diverse pharmaceutical products supporting military medical operations globally.
Quick answers
Who was awarded contract SPE2DB25FQAKB?
SPE2DB25FQAKB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FQAKB worth?
The government has obligated $11,117 on SPE2DB25FQAKB.
Is contract SPE2DB25FQAKB an order under another contract?
Yes. SPE2DB25FQAKB is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB25FQAKB competed?
The extent of competition for SPE2DB25FQAKB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award